Skip to main content
Research:
Research
21 Jun 2021

On Demand Webinar: Pharma’s climate goals

The roadmap to delivery

With influential speakers from AstraZeneca, Roche and Health Care Without Harm, this Reuters webinar in collaboration with Deloitte, explores how companies can embed sustainability into their DNA, shaping long- term business goals and driving economic success.

Experts sharing their knowledge, include:
  • Dr. Peter Schnurrenberger, Chief Security, Health & Environmental Protection (SHE) Officer, Roche
  • Gary Cohen, President, Health Care Without Harm
  • Nazneen Rahman, CEO/Founder, YewMaker (executive partner of the Sustainable Medicines Partnership) and Non-Executive Director at AstraZeneca
  • James Gregson, Partner, Deloitte

Key learnings include:
  • How reputation, duty of care, regulation and competitive advantage factors come together to drive pharma’s climate friendly ambitions
  • Approaches to integrate emission reduction commitments into the DNA of your organisation to result in business and environmental benefits
  • See what new talent, investments and operating models are required to ensure the required cultural and strategic transformations
  • Explore how pressure from and collaboration with wider healthcare stakeholders, such as the public, providers and policy makers, can help to further move the dial and deliver change for the broader ecosystem

Tune into this on demand webinar to learn about the roadmap to climate goal delivery

Did you find this useful?

Yes
No

Thanks for your feedback

If you would like to help improve Deloitte.com further, please complete a 3-minute survey

Your feedback is important to us

To tell us what you think, please update your settings to accept analytics and performance cookies.

Need help updating cookies?

Get in touch

James Gregson

Partner
+44 (0)20 7007 8866

Recommendations

Better public health driving better public | Deloitte UK

Public health is a priority for governments everywhere, with a higher percentage of funding devoted to public health. National statutory public health organisations are responsible for building and maintaining a robust and responsive public health infrastructure – with regionally coordinated public health agencies, a diverse and well-qualified workforce and modern data systems. Non-traditional enterprises also work together, focussing on best-practice protection, prevention and promotion aimed at tackling health inequalities. Digital inclusion and adoption of scientific and technological advancements have reduced health risks and improved prevention. The public health system is underpinned by intelligent national screening and vaccination programmes that focus on high-risk populations through better use of technology, genomics and AI.
Research
10 minute read

Proposed changes to the Finance Act impacting R&D claims for life sciences companies | Deloitte UK

Life sciences companies have been benefiting from the R&D tax relief schemes, with the incentive being invested in the innovative activities these companies have claimed.
Research
minute read

Healthcare Sustainability: Life Sciences Decarbonisation | Deloitte UK

Our healthcare sustainability predictions look towards a future where green energy is abundant and funding is prioritised to help meet net-zero goals.
Research
minute read